{"id":8710,"date":"2017-10-25T05:28:49","date_gmt":"2017-10-25T05:28:49","guid":{"rendered":"https:\/\/www.rootsanalysis.com\/blog\/?p=8710"},"modified":"2026-07-23T15:42:52","modified_gmt":"2026-07-23T10:12:52","slug":"biopharmaceutical-contract-manufacturing-transforming-promise-into-reality","status":"publish","type":"post","link":"https:\/\/www.rootsanalysis.com\/blog\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\/","title":{"rendered":"Biopharma Contract Manufacturing: From Promise to Reality"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">The development and manufacturing processes opted by <a href=\"https:\/\/www.rootsanalysis.com\/blog\/impact-of-biologics-on-contract-manufacturing-industry\/\">biologics CMO<\/a> are complex, and usually require advanced capabilities and specialized expertise. This has led many stakeholders in the industry to outsource significant parts of their business operations to biopharma contract manufacturing service providers. The&nbsp;\u2018Biopharmaceutical Contract Manufacturing Market (2nd edition), 2017 &#8211; 2027\u2019&nbsp;report provides an extensive study of the biopharma contract manufacturing market for biologics.Some of the most interesting insights from our study are presented below.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>The Landscape Of Biopharma Contract Manufacturing Is Steadily Evolving<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Outsourcing activities have grown significantly within the biopharmaceuticals domain; we came across 216 companies offering contract manufacturing services.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>CMOs Have Expanded Their Service Portfolios To Stay Competitive<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">In order to maintain a competitive edge in the growing biopharma contract manufacturing market, CMOs are rapidly expanding their capabilities \/ offerings<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"296\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Biopharmaceutical-Contract-Manufacturing-Distribution-by-Scale-of-Operation-Roots.webp\" alt=\"As per Roots Analysis, currently majority of biopharmaceutical contract manufacturers are manufacturing proteins and peptides.\" class=\"wp-image-18483\" style=\"object-fit:contain;width:800px;height:352px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Biopharmaceutical-Contract-Manufacturing-Distribution-by-Scale-of-Operation-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Biopharmaceutical-Contract-Manufacturing-Distribution-by-Scale-of-Operation-Roots-300x132.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>As The Focus On Biologics Strengthens, CMOs Are Ready To Monetize The Opportunity<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The growing pipelines of emerging therapeutic classes, such as cell and <a href=\"https:\/\/www.rootsanalysis.com\/reports\/gene-therapies-market\/268.html\">gene therapy<\/a>, offer lucrative business opportunities to CMOs in this domain<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Likewise, The Emergence Of Biosimilars Has Reinforced The Promise<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The growing biosimilars market is also expected to be one of the key growth drivers for biopharmaceutical contract manufacturers<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>The Manufacturing Capacity Is Well-Distributed Across The Globe<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The current global biopharma contract manufacturing capacity is over 3.4 million litres; this is well distributed across different regions<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"437\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Biopharmaceutical-Contract-Manufacturing-Capacity-Analysis-Roots.webp\" alt=\"Majority of companies based in North America have largest biomanufacturing installed capacity- Roots Analysis\" class=\"wp-image-18484\" style=\"object-fit:contain;width:800px;height:520px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Biopharmaceutical-Contract-Manufacturing-Capacity-Analysis-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Biopharmaceutical-Contract-Manufacturing-Capacity-Analysis-Roots-300x195.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>We Expect The Overall Market To Witness a Healthy Growth Rate<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Driven by an increasing global demand for biologics, we expect the market to witness significant growth over the coming decade<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Specific Regions, Though, Are Likely To Garner Relatively Higher Interest<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Although preferences regarding expression systems are unlikely to change, the regional <a href=\"https:\/\/www.rootsanalysis.com\/reports\/biopharmaceutical-contract-manufacturing-market\/250.html\">biologics contract manufacturing market<\/a> landscape is likely to evolve in the near future<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"404\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Biopharmaceutical-Contract-Manufacturing-Market-Forecast-Roots.webp\" alt=\"The Biomanufacturing Contract Manufacturing market is fragmented across different segmentations, By 2035, North America is expected to capture the highest share- Roots Analysis\" class=\"wp-image-18485\" style=\"aspect-ratio:1.6842105263157894;object-fit:contain;width:800px;height:auto\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Biopharmaceutical-Contract-Manufacturing-Market-Forecast-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Biopharmaceutical-Contract-Manufacturing-Market-Forecast-Roots-300x180.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\">To know more please click&nbsp;<strong><a href=\"https:\/\/www.rootsanalysis.com\/reports\/biopharmaceutical-contract-manufacturing-market\/250.html\">Biologics Contract Maufacturing Market<\/a><\/strong>&nbsp;For any queries \/ suggestions or if you\u2019d like to get access to the full research results, please do not hesitate to contact us at&nbsp;<strong><a href=\"mailto:sales@rootsanalysis.com\">sales@rootsanalysis.com<\/a><\/strong>. You can also download the&nbsp;<a href=\"https:\/\/www.rootsanalysis.com\/reports\/250\/request-sample.html\">SAMPLE REPORT<\/a>&nbsp;on biologics contract manufacturing by Roots Analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The development and manufacturing processes opted by biologics CMO are complex, and usually require advanced capabilities and specialized expertise. This has led many stakeholders in the industry to outsource significant parts of their business operations to biopharma contract manufacturing service providers. The&nbsp;\u2018Biopharmaceutical Contract Manufacturing Market (2nd edition), 2017 &#8211; 2027\u2019&nbsp;report provides an extensive study of [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":11946,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[287],"tags":[458,288,202,388],"class_list":["post-8710","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biopharmaceutical","tag-analysis","tag-biopharmaceutical","tag-research","tag-rootsanalysis"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biopharma Contract Manufacturing: Key Landscape Insights<\/title>\n<meta name=\"description\" content=\"According to Roots Analysis, the current global biopharma contract manufacturing capacity is over 3.4 million litres.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rootsanalysis.com\/blog\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biopharma Contract Manufacturing: Key Landscape Insights\" \/>\n<meta property=\"og:description\" content=\"According to Roots Analysis, the current global biopharma contract manufacturing capacity is over 3.4 million litres.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rootsanalysis.com\/blog\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RootsAnalysis\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-10-25T05:28:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-23T10:12:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/10\/Slide0-min14.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"1054\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Arun Gupta\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:site\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Arun Gupta\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\\\/\"},\"author\":{\"name\":\"Arun Gupta\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/af9198bf467c6e126793d9da458a1f62\"},\"headline\":\"Biopharma Contract Manufacturing: From Promise to Reality\",\"datePublished\":\"2017-10-25T05:28:49+00:00\",\"dateModified\":\"2026-07-23T10:12:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\\\/\"},\"wordCount\":349,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/Slide0-min14.png\",\"keywords\":[\"analysis\",\"Biopharmaceutical\",\"Research\",\"RootsAnalysis\"],\"articleSection\":[\"Biopharmaceutical\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\\\/\",\"name\":\"Biopharma Contract Manufacturing: Key Landscape Insights\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/Slide0-min14.png\",\"datePublished\":\"2017-10-25T05:28:49+00:00\",\"dateModified\":\"2026-07-23T10:12:52+00:00\",\"description\":\"According to Roots Analysis, the current global biopharma contract manufacturing capacity is over 3.4 million litres.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/Slide0-min14.png\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/Slide0-min14.png\",\"width\":1280,\"height\":1054,\"caption\":\"Antibody Drug Conjugates: Riding on the Second Growth Wave\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biopharma Contract Manufacturing: From Promise to Reality\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Roots Analysis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\",\"name\":\"Roots Analysis\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"width\":205,\"height\":61,\"caption\":\"Roots Analysis\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RootsAnalysis\\\/\",\"https:\\\/\\\/x.com\\\/RootsAnalysis\",\"https:\\\/\\\/www.instagram.com\\\/rootsanalysis\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/roots-analysis\\\/\",\"https:\\\/\\\/www.pinterest.it\\\/analysis1340\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCwZF57vY1lnU0bNLej2zukg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/af9198bf467c6e126793d9da458a1f62\",\"name\":\"Arun Gupta\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"caption\":\"Arun Gupta\"},\"description\":\"Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT &amp; technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biopharma Contract Manufacturing: Key Landscape Insights","description":"According to Roots Analysis, the current global biopharma contract manufacturing capacity is over 3.4 million litres.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rootsanalysis.com\/blog\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\/","og_locale":"en_US","og_type":"article","og_title":"Biopharma Contract Manufacturing: Key Landscape Insights","og_description":"According to Roots Analysis, the current global biopharma contract manufacturing capacity is over 3.4 million litres.","og_url":"https:\/\/www.rootsanalysis.com\/blog\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\/","og_site_name":"Blog","article_publisher":"https:\/\/www.facebook.com\/RootsAnalysis\/","article_published_time":"2017-10-25T05:28:49+00:00","article_modified_time":"2026-07-23T10:12:52+00:00","og_image":[{"width":1280,"height":1054,"url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/10\/Slide0-min14.png","type":"image\/png"}],"author":"Arun Gupta","twitter_card":"summary_large_image","twitter_creator":"@RootsAnalysis","twitter_site":"@RootsAnalysis","twitter_misc":{"Written by":"Arun Gupta","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rootsanalysis.com\/blog\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\/#article","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\/"},"author":{"name":"Arun Gupta","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/af9198bf467c6e126793d9da458a1f62"},"headline":"Biopharma Contract Manufacturing: From Promise to Reality","datePublished":"2017-10-25T05:28:49+00:00","dateModified":"2026-07-23T10:12:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\/"},"wordCount":349,"publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/10\/Slide0-min14.png","keywords":["analysis","Biopharmaceutical","Research","RootsAnalysis"],"articleSection":["Biopharmaceutical"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rootsanalysis.com\/blog\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\/","url":"https:\/\/www.rootsanalysis.com\/blog\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\/","name":"Biopharma Contract Manufacturing: Key Landscape Insights","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\/#primaryimage"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/10\/Slide0-min14.png","datePublished":"2017-10-25T05:28:49+00:00","dateModified":"2026-07-23T10:12:52+00:00","description":"According to Roots Analysis, the current global biopharma contract manufacturing capacity is over 3.4 million litres.","breadcrumb":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rootsanalysis.com\/blog\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\/#primaryimage","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/10\/Slide0-min14.png","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/10\/Slide0-min14.png","width":1280,"height":1054,"caption":"Antibody Drug Conjugates: Riding on the Second Growth Wave"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rootsanalysis.com\/blog\/biopharmaceutical-contract-manufacturing-transforming-promise-into-reality\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rootsanalysis.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Biopharma Contract Manufacturing: From Promise to Reality"}]},{"@type":"WebSite","@id":"https:\/\/www.rootsanalysis.com\/blog\/#website","url":"https:\/\/www.rootsanalysis.com\/blog\/","name":"Blog","description":"Roots Analysis","publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rootsanalysis.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization","name":"Roots Analysis","url":"https:\/\/www.rootsanalysis.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","width":205,"height":61,"caption":"Roots Analysis"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RootsAnalysis\/","https:\/\/x.com\/RootsAnalysis","https:\/\/www.instagram.com\/rootsanalysis\/","https:\/\/www.linkedin.com\/company\/roots-analysis\/","https:\/\/www.pinterest.it\/analysis1340\/","https:\/\/www.youtube.com\/channel\/UCwZF57vY1lnU0bNLej2zukg"]},{"@type":"Person","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/af9198bf467c6e126793d9da458a1f62","name":"Arun Gupta","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","caption":"Arun Gupta"},"description":"Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT &amp; technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients."}]}},"_links":{"self":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/8710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/comments?post=8710"}],"version-history":[{"count":6,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/8710\/revisions"}],"predecessor-version":[{"id":22354,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/8710\/revisions\/22354"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media\/11946"}],"wp:attachment":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media?parent=8710"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/categories?post=8710"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/tags?post=8710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}